38842585|t|Rotenone Induces a Neuropathological Phenotype in Cholinergic-like Neurons Resembling Parkinson's Disease Dementia (PDD).
38842585|a|Parkinson's disease with dementia (PDD) is a neurological disorder that clinically and neuropathologically overlaps with Parkinson's disease (PD) and Alzheimer's disease (AD). Although it is assumed that alpha-synuclein ( alpha -Syn), amyloid beta (A beta ), and the protein Tau might synergistically induce cholinergic neuronal degeneration, presently the pathological mechanism of PDD remains unclear. Therefore, it is essential to delve into the cellular and molecular aspects of this neurological entity to identify potential targets for prevention and treatment strategies. Cholinergic-like neurons (ChLNs) were exposed to rotenone (ROT, 10 mu M) for 24 h. ROT provokes loss of Delta Psi m   , generation of reactive oxygen species (ROS), phosphorylation of leucine-rich repeated kinase 2 (LRRK2 at Ser935) concomitantly with phosphorylation of alpha -synuclein ( alpha -Syn, Ser129), induces accumulation of intracellular A beta (iA beta ), oxidized DJ-1 (Cys106), as well as phosphorylation of TAU (Ser202/Thr205), increases the phosphorylation of c-JUN (Ser63/Ser73), and increases expression of proapoptotic proteins TP53, PUMA, and cleaved caspase 3 (CC3) in ChLNs. These neuropathological features resemble those reproduced in presenilin 1 (PSEN1) E280A ChLNs. Interestingly, anti-oxidant and anti-amyloid cannabidiol (CBD), JNK inhibitor SP600125 (SP), TP53 inhibitor pifithrin- alpha (PFT), and LRRK2 kinase inhibitor PF-06447475 (PF475) significantly diminish ROT-induced oxidative stress (OS), proteinaceous, and cell death markers in ChLNs compared to naive ChLNs. In conclusion, ROT induces p- alpha -Syn, iA beta , p-Tau, and cell death in ChLNs, recapitulating the neuropathology findings in PDD. Our report provides an excellent in vitro model to test for potential therapeutic strategies against PDD. Our data suggest that ROT induces a neuropathologic phenotype in ChLNs similar to that caused by the mutation PSEN1 E280A.
38842585	0	8	Rotenone	Chemical	MESH:D012402
38842585	86	114	Parkinson's Disease Dementia	Disease	MESH:D010300
38842585	116	119	PDD	Disease	MESH:D010300
38842585	122	155	Parkinson's disease with dementia	Disease	MESH:D010300
38842585	157	160	PDD	Disease	MESH:D010300
38842585	167	188	neurological disorder	Disease	MESH:D009461
38842585	243	262	Parkinson's disease	Disease	MESH:D010300
38842585	264	266	PD	Disease	MESH:D010300
38842585	272	291	Alzheimer's disease	Disease	MESH:D000544
38842585	293	295	AD	Disease	MESH:D000544
38842585	326	341	alpha-synuclein	Gene	6622
38842585	344	354	alpha -Syn	Gene	6622
38842585	357	369	amyloid beta	Gene	351
38842585	371	377	A beta	Gene	351
38842585	397	400	Tau	Gene	4137
38842585	430	463	cholinergic neuronal degeneration	Disease	MESH:D009410
38842585	505	508	PDD	Disease	MESH:D010300
38842585	610	629	neurological entity	Disease	MESH:D009461
38842585	750	758	rotenone	Chemical	MESH:D012402
38842585	760	763	ROT	Chemical	MESH:D012402
38842585	784	787	ROT	Chemical	MESH:D012402
38842585	835	858	reactive oxygen species	Chemical	MESH:D017382
38842585	860	863	ROS	Chemical	MESH:D017382
38842585	917	922	LRRK2	Gene	120892
38842585	972	988	alpha -synuclein	Gene	6622
38842585	991	1001	alpha -Syn	Gene	6622
38842585	1050	1056	A beta	Gene	351
38842585	1078	1082	DJ-1	Gene	11315
38842585	1123	1126	TAU	Gene	4137
38842585	1177	1182	c-JUN	Gene	3725
38842585	1248	1252	TP53	Gene	7157
38842585	1254	1258	PUMA	Gene	27113
38842585	1272	1281	caspase 3	Gene	836
38842585	1360	1372	presenilin 1	Gene	5663
38842585	1374	1379	PSEN1	Gene	5663
38842585	1381	1386	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
38842585	1439	1450	cannabidiol	Chemical	MESH:D002185
38842585	1452	1455	CBD	Chemical	MESH:D002185
38842585	1458	1461	JNK	Gene	5599
38842585	1472	1480	SP600125	Chemical	MESH:C432165
38842585	1482	1484	SP	Chemical	MESH:C432165
38842585	1487	1491	TP53	Gene	7157
38842585	1502	1518	pifithrin- alpha	Chemical	MESH:C121565
38842585	1520	1523	PFT	Chemical	MESH:C121565
38842585	1553	1564	PF-06447475	Chemical	MESH:C000597233
38842585	1566	1571	PF475	Chemical	MESH:C000597233
38842585	1596	1599	ROT	Chemical	MESH:D012402
38842585	1718	1721	ROT	Chemical	MESH:D012402
38842585	1833	1836	PDD	Disease	MESH:D010300
38842585	1939	1942	PDD	Disease	MESH:D010300
38842585	1966	1969	ROT	Disease	
38842585	2054	2059	PSEN1	Gene	5663
38842585	2060	2065	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
38842585	Negative_Correlation	MESH:D002185	MESH:D012402
38842585	Association	MESH:D012402	120892
38842585	Positive_Correlation	MESH:D012402	3725
38842585	Association	MESH:C121565	MESH:D010300
38842585	Positive_Correlation	MESH:D012402	27113
38842585	Negative_Correlation	MESH:C000597233	MESH:D012402
38842585	Association	MESH:D012402	11315
38842585	Negative_Correlation	MESH:C000597233	7157
38842585	Positive_Correlation	MESH:D012402	351
38842585	Negative_Correlation	MESH:C000597233	MESH:D000544
38842585	Positive_Correlation	MESH:D012402	7157
38842585	Association	MESH:D010300	351
38842585	Positive_Correlation	MESH:D009410	351
38842585	Negative_Correlation	MESH:C121565	7157
38842585	Negative_Correlation	MESH:C432165	5599
38842585	Association	MESH:D009410	6622
38842585	Negative_Correlation	MESH:D002185	MESH:D010300
38842585	Positive_Correlation	MESH:D012402	836
38842585	Negative_Correlation	MESH:D012402	MESH:D010300
38842585	Association	MESH:D010300	5663
38842585	Positive_Correlation	MESH:D012402	6622
38842585	Association	MESH:D010300	6622
38842585	Association	MESH:D009410	4137
38842585	Positive_Correlation	MESH:D012402	MESH:D017382
38842585	Association	MESH:D012402	4137
38842585	Association	MESH:D010300	4137

